Department of Biology, Stanford University, 371 Serra Mall, Stanford, CA 94305-5020, USA.
Transl Stroke Res. 2011 Mar 1;2(1):92-100. doi: 10.1007/s12975-010-0060-2.
Gene therapy has demonstrated the protective potential of a variety of genes against stroke. However, conventional gene therapy vectors are limited due to the inability to temporally control their expression, which can sometimes lead to deleterious side effects. Thus, an inducible vector that can be temporally controlled and activated by the insult itself would be advantageous. Using hypoxia responsive elements (HRE) and antioxidant responsive elements (ARE), we have constructed an insult-inducible vector activated by hypoxia and reactive oxygen species (ROS). In COS7 cells, the inducible ARE-HRE-luciferase vectors are highly activated by oxygen deprivation, hydrogen peroxide treatment, and the ROS-induced transcription factor NF-E2-related factor 2 (Nrf2). Using a defective herpes virus, the neuroprotective potential of this inducible vector was tested by over-expressing the transcription factor Nrf2. In primary cortical cultures, expression of the inducible ARE-HRE-Nrf2 protects against oxygen glucose deprivation, similar to that afforded by the constitutively expressed Nrf2. This ARE+HRE vector system is advantageous in that it allows the expression of a transgene to be activated not only during hypoxia but also maintained after reperfusion, thus prolonging the transgene expression during an ischemic insult. This insult-inducible vector system will be a valuable gene therapy tool for activating therapeutic/protective genes in cerebrovascular diseases.
基因治疗已经证明了多种基因对中风的保护潜力。然而,由于传统的基因治疗载体不能对其表达进行时间控制,有时会导致有害的副作用,因此,一种可以通过损伤本身进行时间控制和激活的诱导载体将是有利的。我们利用缺氧反应元件(HRE)和抗氧化反应元件(ARE)构建了一种由缺氧和活性氧(ROS)激活的损伤诱导载体。在 COS7 细胞中,缺氧诱导的 ARE-HRE-荧光素酶载体可被缺氧、过氧化氢处理以及 ROS 诱导的转录因子核因子红细胞 2 相关因子 2(Nrf2)高度激活。利用一种缺陷型疱疹病毒,通过过表达转录因子 Nrf2 来测试这种诱导载体的神经保护潜力。在原代皮质培养物中,诱导型 ARE-HRE-Nrf2 的表达可防止氧葡萄糖剥夺,与组成型表达的 Nrf2 提供的保护作用相似。这个 ARE+HRE 载体系统的优点在于,它不仅可以在缺氧时激活转基因的表达,而且可以在再灌注后维持表达,从而在缺血性损伤期间延长转基因的表达。这种损伤诱导型载体系统将成为激活脑血管疾病治疗/保护基因的有价值的基因治疗工具。